Back to search

Article

Inflammatory Modulation of Bronchial Epithelial Cells’ Response to Lipopolysaccharide with Pretreatment by Montelukast

2021-04-05

Abstract excerpt

<title>Abstract</title> <p>Purpose Montelukast, a leukotriene receptor antagonist, is the most prescribed non-steroidal anti-inflammatory drug used as add-on therapy at later stages of asthma to prevent disease progression. Besides its direct anti-inflammatory effect due to blocking leukotriene action, montelukast has been proposed to have secondary anti-inflammatory and anti-fibrotic properties. This study aime...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf703140-ca5c-50f0-ad53-79ea13256ffc
DOI
10.21203/rs.3.rs-389828/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inflammatory Modulation of Bronchial Epithelial Cells’ Response to Lipopolysaccharide with Pretreatment by MontelukastDOI 10.21203/rs.3.rs-389828/v1
Select a neighboring publication to make it the new centre.